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Axial heterogeneity of adenosine transport and metabolism in the
rabbit proximal tubule. Transport and metabolism of adenosine were
studied in the SI, S2, and S3 segments of the rabbit proximal renal
tubule. Isolated segments were perfused in vitro with uniformly labelled
'4C-adenosine to measure the lumen-to-bath flux of adenosine. This flux
rate was measured by the disappearance of '4C from the luminal fluid
(ED) and simultaneously by the appearance of '4C in the bathing solution
(JA), expressed as femtomoles per minute per millimeter of tubule
length (fmol mm' mm). At a perfused concentration of 83.3 /ZM
adenosine, when corrected for metabolism, the Js for adenosine in the
Sl, S2, and S3 segments were 735, 212, and 273, respectively. 1A,
corrected for metabolism, were 0, 0, and 4.8 fmol min mm' for
the SI, S2, and S3 segments, indicating that very little or no
adenosine moved across the basolateral membrane. To correct for
metabolism of '4C-adenosine, the perfusion fluid, collected fluid, tubu-
lar extract, and bathing fluid, from three tubules of each segment type,
were analyzed by high-performance liquid chromatography to identify
'4C-adenosine and its '4C-metabolites. At 83.3 tiM, all segments metab-
olized adenosine extensively. Consequently, adenosine-5'-monophos-
phate (AMP) and inosine were found in tubule cells of all segments.
Inosine also appeared in the collected fluid, but AMP did not. In SI and
S2 segments, none of the 14C in the bathing solutions could be identified
and no adenosine was found. Of the small amounts of '4C found in
bathing solutions from S3 segments, about 27% appeared to be adeno-
sine, the rest were inosine and hypoxanthine or unidentified metabo-
lites. Cell-to-lumen adenosine concentration ratios, corrected for me-
tabolism but not for binding, were 7.3, 21.3, and 8.7 for the SI, S2, and
S3 segments, respectively. We conclude that adenosine is avidly
transported across the luminal membrane in all segments of the proxi-
mal tubule and then extensively metabolized. Therefore, any adenosine
in the glomerular filtrate is not likely to appear in renal venous blood or
the urine as adenosine. These data suggest that adenosine in the urine
must come primarily from some point in the nephron distal to the
proximal tubule.
Urinary adenosine concentrations have been related to blood
pressure control [1], but the sources of and mechanisms of
controlling urinary adenosine are not yet known. Urinary
adenosine concentrations are reportedly in the low micromolar
range. Kuttesch, Schmalstieg and Nelson [21 reported mean
urinary adenosine levels of 5.4 4.5 M in human urine, Miller
et al [31 reported0.5 to 2.5 LM (our calculations) in canine urine.
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Katholi, McCann and Woods [1] reported urine adenosine
concentrations in normotensive rats of about 1 M. In the same
study, one-kidney, one-clip rats had a mean urinary adenosine
concentration of 3 /.LM.
Based on reported values for plasma adenosine concentration
of 100 to 200 nM in humans [4] and representative values for
glomerular filtration rate, renal plasma flow, and urine flow, it
can be calculated that much more adenosine is filtered than is
excreted. Thus, it is speculated that filtered adenosine is
absorbed somewhere along the nephron [21. More recently
McCann and Katholi [5] and Findley et al [6] have reported
plasma adenosine concentrations of 13 to 35 flM in humans. If
this is correct, then all urinary adenosine could originate by
glomerular filtration.
Studies [7] with the isolated perfused rat kidney demon-
strated net adenosine absorption at perfusate concentrations
below 40 LM, and net secretion at higher perfusate concentra-
tions. Experiments with isolated luminal and basolateral mem-
brane vesicles indicate that adenosine transport across these
membranes is a carrier mediated process [7]. Another study
with luminal membrane vesicles demonstrated that this Na-
dependent transport process showed an "overshoot", indicat-
ing active transport [8]. These studies [7, 8] determined that the
Km value for the adenosine transport system ranged from 1 to
40 LM. With bolus injections of adenosine into the renal artery,
Thompson, Sparks and Spielman [9] found that practically all
adenosine delivered to the kidney was sequestered by the renal
tissue or excreted in the urine. The urinary adenosine appeared
to have come from glomerular filtration and tubular secretion,
indicating adenosine was sequestered by luminal and basolat-
eral membranes.
Recently, it has been shown [10] that the luminal adenosine in
the region of the macula densa enhanced tubuloglomerular
feedback response. If this is the case, it is important to locate
the source of adenosine to determine its role in tubuloglomer-
ular feedback. Is it derived from glomerular filtration or secre-
tion from a segment of the nephron upstream from the macula
densa?
Our data from isolated perfused tubules presented here
indicate that luminal adenosine is avidly transported from the
luminal fluid and extensively metabolized by the cells of the Si,
S2, and S3 segments of the rabbit proximal tubule. Very little if
any adenosine appears in the bathing solution, although some
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metabolites do appear there. These data suggest that urinary
adenosine does not originate from glomerular filtration but must
come from secretion in the more distal regions of the nephron.
Methods
General plan of experiments
Two sets of studies were done with isolated proximal renal
tubule segments from rabbit. In the first set, tubules were
perfused with solutions containing 3H-methoxyinulin as a vol-
ume marker (75 Ci/ml) and uniformly labelled 14C-adenosine
(6 Ci/ml). '4C-Adenosine concentrations were held at about 20
LM while nonlabeled adenosine was varied to bring the final
adenosine concentration to 83.3, 310, and 1000 M. Samples
from these tubules were assayed for flux of total 3H and '4C. In
the second set of experiments, tubules were perfused with
solutions containing uniformly labelled '4C-adenosine (83.3 M,
25 Ci/m1) and no 3H-methoxyinulin. The samples from these
tubules were subjected to analysis by high pressure liquid
chromatography (HPLC) to determine the extent of '4C incor-
poration into '4C-adenosine metabolites. This adenosine con-
centration is greater than desired but it was necessary to
provide high enough radioactivity in samples for accurate
counting. This resulted because of the low specific activity of
the 14C-adenosine. The amount of radioactivity in tubule ex-
tract, perfusate, and coilectate samples was about 1300 CPM
each while the bath samples were around 200 CPM above
background.
Materials and reagents
Rabbits were obtained from the Willingham Rabbit Farm of
Butler, Georgia, and housed at the animal facilities of Georgia
State University and fed standard rabbit chow and water ad
libitum.
All non-isotopicaily labelled chemicals were analytical grade
and solvents were HPLC grade. Adenosine, adenosine-5'-
monophosphate (AMP), adenine, inosine, xanthosine, xan-
thine, hypoxanthine, and uric acid were obtained from Sigma
Chemical Co. (St. Louis, Missouri, USA). Water used for
perfusion of tubules was glass distilled and that used for HPLC
analysis was HPLC grade (Milli-Q system, Millipore Co.,
Bedford, Massachusetts, USA); reagents were prepared with
deionized water.
Isotopes and counting
3H-methoxyinulin (260 mCi/g) was purchased from New
England Nuclear and extensively dialyzed against distilled
water to remove small 3H fragments. The dialysis tubing
molecular weight cut off was 2,000. Uniformly labelled '4C-
adenosine (300 mCi/mmol) was purchased from ICN Radio-
chemicals (Irvine, California, USA) and used as purchased. Its
radiochemical purity was confirmed by HPLC analysis of the
perfusion solution (Results).
Tubule preparation and perfusion
Common aspects of both sets of experiments for tubule
preparation and perfusion were as follows. SI, S2, and S3
segments of the rabbit proximal tubule were identified, dis-
sected free-hand, isolated, and perfused in vitro as described
previously [11—131. Briefly, the rabbits were decapitated and the
kidneys quickly removed, Coronal slices 1-mm thick were
placed in cold Ringer's solution. The various segments of the
proximal tubule were identified as follows. The Sl segments
were dissected from the surface of the kidney slices and
identified by the larger outside diameter and very convoluted
shape. Occasionally, a glomerulus was found attached for
positive identification. The S2 segments were identified as
tubules that spanned the length of the cortex and had a very
straight shape, The S3 segments were identified as the last 1 mm
of the proximal tubule that was attached to the descending thin
limb of Henle's loop. After dissection, the tubule was mounted
in a bathing solution between perfusion and collection pipets
and perfused by positive pressure (20 to 30 mm Hg) at 10 to 15
nl min1 for 15 to 30 minutes while the bath was warming to
37°C. The length and outer and inner radii (microns) of the
segments were determined at bOx magnification with the aid of
a micrometer disc. Ringer's solution perfused and bathed the
tubule. Additionally, the perfusate contained '4C-adenosine
with 3H-methoxyinulin (75 Ci/ml) in the first set of studies
only. The 3H-methoxyinulin served as a volume marker to
determine changes between perfused and collected volumes
and to measure nonspecific leak from the lumen to the bath. The
composition of the solutions was: Nat, 145 mM; Cl, 140 mM;
K, 5.0 mM; Ca2, 2.5 mM; Mg2, 1.2 mM; S042_, 1.2 mM;
HPO42/H2PO4, 2.0 mM; and butyrate, 90.0 M. The osmolal-
ity was adjusted to 290 mmollkg of H20 by adding water
(Advanced MICRO-OSMOMETER Model 3M0) and the pH
was adjusted to 7.4 by adding NaOH. In addition the bathing
solution contained 0.5 mr L-glutamic acid. The bathing solu-
tion was continually exchanged at the rate of 0.26 ml min1
and collected by aspiration over five-minute periods (1.3 ml
volume) into scintillation vials. The total bath volume was 0.3
ml. In the first set of studies, samples were counted for content
of 3H and 14C to measure the non-specific leak rate with
3H-methoxyinulin and the appearance rate of 14C-adenosine
and its 4C-metabolites in the bathing solution. In the second set
of studies, tubules, collectates, perfusion fluids and baths were
dried and prepared for HPLC analysis (see below).
During each study, fluid collected from the tubules (collec-
tates) was drawn into a 44-ni constant volume pipet and the time
(mm) required was noted. After an initial equilibrium period of
20 to 30 minutes to establish steady state, each tubule was
studied for at least three collection periods (5 mm each). Steady
state was confirmed by noting that the 4C disappearance rate
from the lumen and the '4C appearance rate in the bath were not
changing with time. In the second set experiments, two collec-
tion periods were pooled resulting in 88-ni volume samples for
collectates. These and the corresponding bathing solution sam-
ples were placed directly into scintillation vials in the first set,
but in the second set, the individual samples were injected
directly into 15 1d of water in separate wells of a Terasaki tissue
typing tray (60 wells; perfusate and collectate samples) or into
a scintillation vial (bath samples) and dried at room tempera-
ture.
At the end of each experiment, the tubule was harvested for
determination of the cellular content of '4C-labelled com-
pounds. This was accomplished in less than one second by
grabbing the tubule at the perfusion end with forceps, pulling it
free and out of the bathing solution and placing it in 15 d of
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distilled water. This tubular extract from the first set of exper-
iments was placed in a scintillation vial and counted for all '4C
and 3H activity. Tubules from the second set were treated
similarly, but then were dried in the same way as the collectate
and perfusate samples, and saved for HPLC analysis.
To correct for any '4C-adenosine that was present in the
tubular lumen at the time of harvest, the volume of the luminal
compartment was determined from the amount of volume
marker (CPM) that was harvested with the tubule. This amount
of '4C was subtracted from the total 14C extracted. This
correction was always very small, less that 1% of total cellular
'4c.
HPLC methods
Dried samples from the second set of experiments were
reconstituted in a "standard mixture" containing the following
unlabelled substances: uric acid, 0.028 mM; xanthosine, 0.032
mM; xanthine, 0.027 mM; hypoxanthine, 0.01 mM; inosine, 0.02;
adenine, 0.02 mM; adenosine, 0.02 m. The samples of perfus-
ate, collectate, and tubule extract were reconstituted in 75 d of
"standard mixture" while the dried bath samples were recon-
stituted in 300 d. Fifty microliters of each was used for HPLC
analysis while 10 .d and 75 d, respectively, of the remaining
solution was placed directly into scintillation vials and counted
to determine total sample 14C. This value was used to calculate
the recovery of '4C in the HPLC fractions (see below).
Samples were subjected to HPLC analysis using methods
previously described [14] with minor modifications. In brief, the
procedure employed a Regis ODS 5 micron Spherosorb (octa-
decyl) C-18 column (4.6 mm ID x 25 cm) preceded by a
Brownlee RP-18 pre-column. The injector (Rheodyne) was
fitted with a 50 l loop. Injections were made with the column
running on Buffer A (0.025 M potassium phosphate buffer, pH
7.5) at 1.0 ml min1, At the time of injection, a 15-minute
linear gradient to Buffer B (450 ml Buffer A mixed with 200 ml
methanol) was started. The flow rate remained constant. The
UV detector was set at 250 nm such that 0.1 absorbance units
gave a full-scale recorder pen deflection of 25.4 cm. The
recorder paper was run at 8 mm min . The identity of each
eluting peak, corresponding to each component of the "stan-
dard mixture," was determined by the retention times which
had been determined previously by separate injections of each
substance. A separate mixture of 0.01 mrvi AMP and 0.02 mM
adenosine was also used on each day to determine the AMP
retention time. The peak heights and retention times of these
standards were stable and reproducible from day to day and
within runs and are shown in Fig. 1. This system does not
reliably separate ADP, ATP, and uric acid.
Serial fractions (0.5 ml each) of the eluate were collected
from the flow cell outlet using an LKB Redirac fraction collec-
tor directly into plastic scintillation vials containing scintillation
fluid (see below), following which vials were capped, mixed and
stored at room temperature in the dark. Since flow rate was
constant, each fraction (0.5 ml) was collected every 0.5 min-
utes. Collections were continued for 20 minutes, giving 40
fractions per run. The time delay between the exit of fluid from
the UV detector flow cell and its entry into a vial was estimated
from the flow rate, and the internal diameter and the length of
the tubing, to be about 2 seconds. After completing the collec-
tions in each run, the HPLC buffer system was recycled back to
ADE
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Fig. 1. Chromatogram of standard mixture. The injected concentra-
tion of each component and the HPLC details are given in Methods.
Injection time at 0 minutes (arrow). Abbreviations are: S, solvent front
(artifact); U, uric acid; XO, xanthosine; XI, xanthine; HX, hypoxan-
thine; INO, inosine; ADE, adenine; ADO, adenosine. AMP (dashed
line) peak is superimposed from a separate injection of adenosine-5'-
monophosphate + ADO. In separate trials (not shown) it was found that
ADP and ATP eluted near or before the uric acid peak. The system does
not reliably separate these three compounds.
Buffer A over 1.5 minutes, and the column was allowed to run
on Buffer A for 5 to 6 minutes before the next injection.
Isotope counting procedures
3H and '4C determinations were done with either a Beckman
5800 or L-9000 scintillation counter using standard methods for
separating the radioisotopic activity. In the first set of experi-
ments the scintillation vials contained 8 ml of Packard Opti-
fluor scintillation fluid and 1.3 ml of water to maintain the same
degree of quenching for all samples. Equal quenching was
always confirmed by noting the same H number (Beckman) for
each sample. In the second set of experiments 8 ml of Opti-fluor
only were added to each vial. The windows were set separately
for 3H and '4C channels for vials from the first set which
contained both isotopes, or were open for samples from the
second set which contained only '4C.
Calculations
Transport of adenosine as the disappearance from the lumen
(Jo) was calculated by the equation:
= [I'A x (Ic/Ip) x C] — (CA x C)
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where A and CA are the perfusate arid collectate adenosine
concentrations (fmol!nl) and C is the collection rate (ni/mm). Ic
and Ip are respectively the collectate and perfusate 3H-methoxy-
inulin concentration (CPM/nl). A (fmoi/nl) was determined by
adding a known amount of adenosine to a known volume of
perfusate. Three samples of perfusate were measured for iso-
tope concentration (CPM/nl). This was divided by A (fmoi/nl)
to obtain the specific activity (SA) (CPM/fmol). CA was calcu-
lated by dividing collected '4C (CPM/nl) by SA (CPM/fmol).
Transport measured by appearance in the bathing solution
(JA) was calculated by:
= Bath CPM/(SA >< T)
where Bath CPM is the amount of '4C that appeared in the
bathing solution in T (mm) time. Both D and A were normal-
ized to tubule length (mm).
The cell volume (CV) of each tubule segment was calculated,
as picoliters, from the equation:
CV = [ir(0R2 — 1R2) x L] x 0.7
where OR and IR are the outer and inner radii (microns, sm),
respectively, and L is tubule length (jm) and 0.7 accounts for
the fraction of cellular volume that is water [15, 161.
Cellular adenosine concentration (CC; mM) was calculated by
the equation:
CC = (cpm/SA)/CV
where cpm is the counts per minute of '4C-adenosine that was
in the cellular extract. SA is the specific activity of 14C-
adenosine taken from perfusate (cpm/fmol). Since perfusate
adenosine concentration was probably much higher than in vivo
adenosine concentration, the SA of extracted adenosine was
assumed to be the same as perfusate. If substantial adenosine
were synthesized by the tubule and mixed with the 4C-
adenosine, thus lowering the SA, then the cell concentration
calculated would be an underestimate of the cellular adenosine
concentration. Therefore, our reported cellular adenosine con-
centrations may be minimal values.
Collection rates (C) were calculated from the known volume
collected per study period (44 nI or 88 ni) divided by the time
(minutes) for collection.
In set 1, the 3H-methoxyinulin leak from lumen-to-bath was
measured to determine the integrity of each tubule preparation.
If a tubule leaked more than 1% of the perfused 3H-methoxy-
inulin into the bathing solution, the data were discarded. On
average, three out of ten tubules perfused were rejected. Leak
was calculated by measuring the amount of 3H-methoxyinutin
that appeared in the bath during the five-minute collection
periods (CPM/min). This value was divided by the 3H-methox-
yinulin concentration (CPM/nl) of the perfusate to obtain the
leak value (ni/mm).
The fraction of '4C found in identifiable HPLC fractions
(co-eluting with UV detector signals from known non-labelled
materials in the standard mixture) was calculated by summing
CPM appropriately in HPLC fractions, then dividing by the
total CPM of all 40 vials of eluate. The result is the fraction of
adenosine or its metabolites found in a sample in relation to the
total 14C which the particular sample contained. Values for each
fraction were then converted to percent of total '4C in the
sample.
Table 1. Summary of HPLC analysis of cell extract, collectate,
bathing solution, and perfusate from perfused segments of the
proximal tubule
Segment SI S2 S3
Tubule cell % ADO 21.8 2.9 54.4 6.6 15.0 6.0
Extract % AMP
% INO
%Other
42.8 0.9
18.6 2.2
16.8
17.6 1.9
16.4 6.2
11.6
29.2 5.4
26.2 6.0
29.5
Collectate % ADO
% AMP
% INO
% Other
59.2 5.9
0.0
17.5 3.4
23.3
89.5 1.7
0.3 0.3
5.6 0.9
4.6
83.0 2.5
1.3 0.5
6.6 0.6
9.1
Bathing solution % ADO
% AMP
% INO
% HX
% Other
0.0
0.0
0.0
0.0
100.0
0.0
0.0
0.0
0.0
100.0
27.0 14.9
0.0
16.0 8.1
13.0 6.3
44.0
Perfusate % ADO 96.9 3.1 96.9 3.1 96.9 3.1
The percent of '4C is shown in identifiable HPLC fractions of the total
'4C of samples. The unidentified amounts were mostly in the"pre-uric
acid" or "uric acid" fractions. Data are given as means SEM. N = 3
in all cases. Perfusate adenosine concentration was 83.3 M. Abbrevi-
ations are: ADO, adenosine; AMP, adenosine-5'-monophosphate; INO,
inosine; and HX, hypoxanthine.
The mean luminal concentrations (MLC) of '4C were calcu-
lated by [121:
MLC = (A + CA)!2
Results
This study was undertaken to determine whether urinary
adenosine can be derived from glomerular filtration and
whether filtered adenosine reappears in renal venous blood.
This requires a complete understanding of how the proximal
tubule handles filtered adenosine. Since it is well known [11, 12,
15, 161 that other filtered organic molecules are transported and
metabolized at different rates in the various segments of the
proximal tubule (Si, S2, and S3), it was important to determine
whether axial heterogeneity for adenosine transport and metab-
olism exists.
Figure 1 illustrates a typical HPLC run with the standard
mixture. Retention times were stable within and between days.
It was found in separate studies, not shown, that this system
does not reliably separate ADP, ATP and uric acid, which
eluted in early fractions. Furthermore, it was not possible to
identify the nature of any '4C-containing materials that eluted in
any of these early fractions. On average, 83.4 2.21 (N = 9)
percent of '4C injected was recovered in the eluent.
Table 1 summarizes findings from the HPLC analysis of
samples from set 2 experiments. The data are presented as
means SEM (N = 3 in all cases), showing the percent of total
'4C recovered in HPLC samples which appeared in the adeno-
sine, AMP, and inosine fractions, The perfusate had a mean
content of 96.9 3.1 percent adenosine, not significantly
different from 100 percent. The cells of all segments were found
to contain adenosine, AMP, and inosine and these accounted
for most of the '4C counts, the remainder being found largely in
the "uric" and "pre-uric" samples, with small amounts as
hypoxanthine and adenine. No AMP was found in collectate
samples but all contained inosine as well as adenosine, while
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Table 2. Summary of adenosine transport in the SI, S2, and S3 segments of the proximal tubule
Tubule " JA
Mean luminal
concentration
/.LM
Cell conc.
mM
Cell/lumen
ratio
Tubule length
mmtype fmoI min' mm'
Sl 734.9 58.5 0 62.5 0.6 0.46 0.08 7.33 1.38 0.50 0.06
S2 211.7 43.5 0 71.7 2.5 1.54 0.24 21.3 2.6 1.10 0.08
S3 272.5 52.5 4.8 0.8 70.6 1.9 0.61 0.11 8.7 1.6 0.75 0.07
Data from tubules perfused with 83.3 sM '4C-adenosine corrected for metabolism with data from Table 1. There were five tubules in each group.
Table 3. Summary of total '4C transport in the S I, S2, and S3 segments of the proximal tubule perfused with 20 /SM '4C-adenosine
Segment
type
A Mean luminal
concentration
pM
Cell cone.
m
Cell/lumen
ratio
Tubule length
mmfmol min' mm'
Si 193.9 32.0 43.2 4.7 14.2 0.6 15.6 2.6 1,104.4 208.3 0.53 0.10
S2 46.3 9.3 6.2 1.3 17.7 0.3 9.7 6.7 509.6 294.2 1.50 0.25
S3 15.4 2.5 3.2 0.9 19.9 0.1 1.4 0.4 71.4 20.2 0.73 0.11
Summary of total '4C transport in the SI, S2, and S3 tubule segments. The '4C originated in the perfusion solution as '4C-adenosine. There were
five tubules in each group.
Table 4. Inhibition of total 14C transport (from '4C-adenosine) by non-labeled adenosine in the S2 segment
Non-labeled
adenosine
A Mean luminal
concentration
,uM
Cell cone.
mM
Cell/lumen
ratio
Tubule length
mmfmol min' mm'
0.0 M 46.3 9.3 6.2 1.3 17.7 0.3 9.7 6.7 509.6 294.2 1.50 0.25
310.0 /.LM 22.0 0.8 17.3 0.7 18.7 0.9 0.3 0.06 19.7 4.7 1.28 0.59
1000.0 tLM 8.3 2.2 10.6 1.7 19.6 0.2 0.1 0.01 4.4 0.7 1.22 0.13
Summary of total 14C transport in the SI, S2, and S3 tubule segments in the presence and absence of non-labeled adenosine. The '4C-adenosine
in the perfusion solution was 20 M in the groups with 0.0 and 1000 M non-labeled adenosine while its concentration was 28 /M in the group with
310 M non-labeled adenosine in the perfusate. There were five tubules in each group.
the remaining '4C was found in the "uric" and "pre-uric"
fractions. Bathing fluid (JA) contained very little total '4C (Table
3). What '4C was present was in unidentified fractions except
for bathing fluid from S3 segments, where some of the '4C was
found in adenosine, inosine, and hypoxanthine fractions.
Table 2 summarizes the transport and cellular data from the
first set of experiments corrected for metabolism. The higher
adenosine concentration of 83.3 p.M was required to obtain
sufficient counts of '4C from cellular extracts for HPLC analy-
sis. Correction for metabolism was accomplished by using the
HPLC results in Table 1. The were always greater than the
corresponding JA5 in all segments. The JAS corrected for
metabolism to give '4C-adenosine flux were not different from
zero except for the S3 segment, in which a small amount of
'4C-adenosine crossed the epithelium intact. The cellular con-
centration of 14C-adenosine in the cells was greater than the
luminal concentration for all tubule segments. This is reflected
in the celL/lumen concentration ratios being greater than unity.
The accumulation of adenosine from the luminal fluid was
greatest for the S2, while Si and S3 segments were similar
(Table 2).
Table 3 summarizes the data for set 1 experiments, in which
tubules were perfused with 20 p.M '4C-adenosine but the data
were not corrected for metabolism. As shown for each segment,
Sl, S2, and S3, the total disappearance of '4C always exceeded
the appearance of "C in the bathing solution and there was
substantial cellular accumulation of '4C.
Table 4 shows the inhibitory effect of various luminal con-
centrations of non-labeled adenosine on transport and cellular
accumulation of '4C from '4C-adenosine. The '4C-adenosine
concentration was held about the same at 20 p.M for the 0.0 and
1000 p.M non-labeled adenosine groups and 28 p.M for the 310
p.M group. Increasing the concentration of non-labeled adeno-
sine in the perfusate progressively decreased TD and cellular "C
accumulation. However, simultaneously A progressively in-
creased relative to This resulted in the A of the 1000 p.M
group equaling the D, indicating saturation of all cellular
binding and reactive sites with non-radiolabeled adenosine.
Under these conditions, total cellular '4C was 4.4 times greater
in concentration than luminal '4C-adenosine.
The volume absorption in all three segments was not signif-
icantly different from zero: Si, —0.04 0,05; S2, 0.00 0.05;
S3, 0.06 0.05 (nl min' mm'). This is expected for two
reasons: (1) the perfusion solution was a simple electrolyte
solution that contained no preferentially absorbed solutes (glu-
cose, amino acids, HC03, etc.) that are needed to support
volume absorption [131 and (2) the relative perfusion rate/tubule
length ratio was high. Both of these conditions minimize the
expected increase in luminal 3H-methoxyinulin concentration
that is attributable to volume absorption. Since the expected
increase in collectate 3H-methoxyinulin concentration of 1 to
2%, resulting from the expected volume absorption rate of 0.14
nl min' mm' [13], is within the scintillation counting error,
the measured volume absorption rate was not different from
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zero. The 3H-methoxyinulin also measured lumen-to-bath leak
rates (ni/mm), which were: Sl, 0.13 0.05; 52,0.12 0,03; S3,
0.04 0.01, which are acceptable at less than 1% of perfused
3H-methoxyinulin.
Discussion
Data presented in Table 1 and Table 2 can be evaluated with
respect to the functional and metabolic characteristics of the
tubule segments and analyzed for evidence of possible active
adenosine transport.
The data indicate that all three proximal tubule segments take
up adenosine and metabolize it to AMP and inosine. As
indicated in Table 1, the relative amounts of AMP and adeno-
sine appeared to vary in different segments. Adenosine, as
such, was also found in all three segments of the proximal
tubule.
It is unlikely that much if any cellular '4C-adenosine is
metabolized from the time perfusion is terminated until enzy-
matic activity ceases after harvesting the tubules because the
tubule is never anoxic. Harvest time is short (C 1 second), and
the cells appear to lyse in 2 to 3 seconds and cellular material is
diluted 15,000-fold in the 15 microliters of distilled water. Since
enzymes are probably nonfunctional in water and adenosine is
stable, the extracted "C should closely reflect the cell concen-
tration of the various "C-substances. It was clear that some
systematic process did not disrupt the 14C-adenosine during
HPLC analysis since 97% of the perfusate '4C-adenosine was
recovered in the adenosine fraction (Table 1).
The cell-to-lumen concentration ratios (Table 2) for adeno-
sine suggest that adenosine is actively transported into the cell
at the luminal membrane. However, some of the cellular
"'C-adenosine is undoubtedly bound [3] and is released when
the cells are lysed. This would not be detected by the chro-
matographic procedure we used to correct for adenosine me-
tabolism. In this study, we observed cellular adenosine levels
much higher than those previously reported [17, 18]. We found
levels as high as 1.54 m while others have reported concen-
trations of 0.0056 and 0.07 m. One explanation for this
difference may be the supraphysiological adenosine concentra-
tion (83.3 MM) used in these experiments. Other reported values
were taken from tissue that was exposed to circulating levels of
adenosine, which may be as low as 60 nM [9J. It is interesting
that even when the cell adenosine concentration was as high as
0.46 m in the Sl and 1.54mM in the 52 segment no adenosine
appeared in the bathing solution. This indicates one of two
things: that the basolateral membrane is quite impermeable to
adenosine or that the cellular adenosine is tenaciously retained
in the cell. The results in Table 4 support the latter position, in
that the appearance of "C in the bathing solution (IA) is equal
to the disappearance of '4C (Jo) from the lumen when there is a
large excess of non-labeled adenosine in the luminal fluid. Thus,
when all adenosine binding sites in the cytoplasm are occupied
by non-labeled adenosine, the '4C-adenosine (or metabolites)
are free to diffuse out of the cell. Since under these conditions
'4C-labeled compounds cross the basolateral membrane, it is
unlikely that this membrane is impermeable to adenosine or its
metabolites.
The celL1lumen ratio of 4.4 for 14C when all cellular binding
sites are saturated with non-labeled adenosine (1000 MM group,
Table 4) supports the notion of active adenosine transport at the
luminal membrane. However, since these samples were not
subjected to HPLC analysis to determine whether all the '4C
extracted was still in the form of adenosine, active transport of
adenosine can not be absolutely proven by these experiments.
The finding that collectates contained inosine indicates either
than inosine returned to the lumen from the cells across the
luminal membrane, which we consider unlikely because inosine
did not appear in the bathing solution, or that the luminal brush
border of the tubules contain adenosine deaminase located in
the luminal compartment. We consider the latter to be more
likely. This notion is in agreement with recent evidence that
shows adenosine deaminase-complexing protein is located in
the surface of the proximal tubule microvilli [20]. This means
that the adenosine transport rates reported in Table 2 may be 4
to 15% less than indicated, but these values can be viewed as
the actual rate of disappearance of luminal adenosine which is
the important physiological fact. It appears that the Si segment
has the greatest extracellular adenosine deaminase activity, as
manifested by the greater amount of inosine in the collected
fluid.
There was marked axial heterogeneity of adenosine metabo-
lism and absorption along the proximal tubule (Tables 1 and 2).
The rate of adenosine disappearance from the luminal fluid
progressively decreased along the proximal tubule from the 51
to the S2 and S3 segments. This is very similar to the reported
axial heterogeneity of the transport rate of other filtered organic
solutes, namely amino acids and monosaccharides [12, 15].
Axial heterogeneity of adenosine metabolism appeared to vary
among the segments. Sl and S2 metabolized cellular adenosine
extensively and to a similar extent, 80%. Luminal adenosine
was more extensively metabolized in the SI segment than in the
S2 or S3. This probably reflects differences in the activity of
degradation enzymes among segments.
A measurements not corrected for metabolism showed that
some of the '4C that disappeared from the lumen appeared in
the bathing solution (Table 3). The difference was sequestered
in the cells as adenosine or as some of the many metabolites of
adenosine. The cell levels of "C were very high. This reflects
that the tubules had taken up much of the perfused adenosine
from the moment they were perfused until they were harvested,
which included 20 to 30 minutes of equilibration time and the
time during which the flux measurements were made. JA
measurements corrected for metabolism indicate that no ab-
sorbed adenosine crossed the tubule intact in the Si and S2
segments. In fact, in these two segments, none of the "C
appearing in the bathing solution could be identified. The S3
segment appeared to transport a small amount of adenosine and
some of its metabolites across the basolateral membrane into
the bathing solution. This process may be passive.
The magnitude of the adenosine disappearance rate from the
luminal fluid (ED) of 735 fmol . min' mm' in the S3 segment
is sufficient to remove all filtered adenosine, thus preventing
any filtered adenosine from appearing in the more distal seg-
ments of the nephron. This calculation depends on an individual
nephron glomerular filtration rate of 20 nl' min' [20] and a
plasma adenosine level as high as 200 nrvi [4]; thus 4.0 fmoles of
adenosine are filtered every minute by each glomerulus. Given
that the Si segment of the rabbit is 5 to 7 mm in length, the 4
fmoles of adenosine filtered per minute would be quickly and
completely removed from the luminal fluid. This suggests that
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urinary adenosine must come from some source other than the
glomerular filtrate, because the tubular fluid must still flow
through the S2 and S3 segments of the proximal tubule before it
arrives at the distal segments of the nephron.
Germane to this issue that no filtered adenosine is present in
the luminal fluid distal to the proximal tubule is the notion that
luminal adenosine signals or influences tubuloglomerular feed-
back. Franco, Bell and Navar [101 recently demonstrated in the
rat that adenosine affects tubuloglomerular feedback. Stimula-
tion of the luminal adenosine receptors in the region of the
macula densa markedly enhanced tubuloglomerular feedback
while blocking the luminal adenosine receptors inhibited
tubuloglomerular feedback. If adenosine signals or influences
tubuloglomerular feedback, then its source must be the loop of
Henle or the thick ascending limb, since our study indicates that
filtered adenosine is absorbed in the proximal tubule.
We conclude that adenosine is avidly removed from the
luminal fluid of all segments of the proximal tubule by luminal
surface metabolism and absorption. The observed disappear-
ance rate is great enough to prevent filtered adenosine from
appearing in the urine. Further, the metabolism of the absorbed
adenosine is great enough to prevent filtered adenosine from
appearing in the venous blood.
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